161 related articles for article (PubMed ID: 35079981)
1. Polarity protein Par3 sensitizes breast cancer to paclitaxel by promoting cell cycle arrest.
Zhao Y; Peng H; Liang L; Li Y; Hu X; Wang B; Xu Y; Chen S
Breast Cancer Res Treat; 2022 Feb; 192(1):75-87. PubMed ID: 35079981
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
Zhao W; Song Y; Xu B; Zhan Q
Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
[TBL] [Abstract][Full Text] [Related]
3. End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability.
Luo Y; Li D; Ran J; Yan B; Chen J; Dong X; Liu Z; Liu R; Zhou J; Liu M
Protein Cell; 2014 Jun; 5(6):469-79. PubMed ID: 24748116
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
5. A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis.
Moktan S; Ryppa C; Kratz F; Raucher D
Invest New Drugs; 2012 Feb; 30(1):236-48. PubMed ID: 20938714
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic Cl- Affects the Anticancer Activity of Paclitaxel in the Gastric Cancer Cell Line, MKN28 Cell.
Tanaka S; Miyazaki H; Shiozaki A; Ichikawa D; Otsuji E; Marunaka Y
Cell Physiol Biochem; 2017; 42(1):68-80. PubMed ID: 28554181
[TBL] [Abstract][Full Text] [Related]
7. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
[TBL] [Abstract][Full Text] [Related]
8. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
9. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.
Sun X; Li D; Yang Y; Ren Y; Li J; Wang Z; Dong B; Liu M; Zhou J
J Pathol; 2012 Mar; 226(4):666-73. PubMed ID: 21989536
[TBL] [Abstract][Full Text] [Related]
12. Loss of polarity protein Par3 is mediated by transcription factor Sp1 in breast cancer.
Zhao Y; Yao D; Li Y; Zhang S; Tao Z; Zhang L; Hu X; Wang B; Chen S
Biochem Biophys Res Commun; 2021 Jul; 561():172-179. PubMed ID: 34023783
[TBL] [Abstract][Full Text] [Related]
13. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
[TBL] [Abstract][Full Text] [Related]
14. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
[TBL] [Abstract][Full Text] [Related]
15. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.
Bonham MJ; Galkin A; Montgomery B; Stahl WL; Agus D; Nelson PS
J Natl Cancer Inst; 2002 Nov; 94(21):1641-7. PubMed ID: 12419791
[TBL] [Abstract][Full Text] [Related]
16. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
[TBL] [Abstract][Full Text] [Related]
17. Bromodomain‑containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2‑antagonist/killer protein.
Ma J; Niu W; Wang X; Zhou Y; Wang H; Liu F; Liu Y; Guo J; Xiong W; Zeng Z; Fan S; Li X; Nie X; Li G; Gui R; Luo Y; Zhou M
Oncol Rep; 2019 Mar; 41(3):1487-1496. PubMed ID: 30592293
[TBL] [Abstract][Full Text] [Related]
18. Enriched variations in TEKT4 and breast cancer resistance to paclitaxel.
Jiang YZ; Yu KD; Peng WT; Di GH; Wu J; Liu GY; Shao ZM
Nat Commun; 2014 May; 5():3802. PubMed ID: 24823476
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells.
Banerjee M; Singh P; Panda D
FEBS J; 2010 Aug; 277(16):3437-48. PubMed ID: 20646066
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
